Trophoblast giant cells express NF-κB2 during early mouse development

Developmental Genetics

Volumn 25, Issue 1, 1999, Pages 23-30

  Muggia, Anna ^a   Teesalu, Tambet ^a   Neri, Antonino ^b   Blasi, Francesco ^a   Talarico, Daniela ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Dipto di Ric Biol e Tecnologica   (Italy)

Author keywords

Early mouse development; Immunohistochemistry; In situ hybridization; In vitro culture of ectoplacental cone; NF B transcription factors; nfkb2; Trophoblast giant cells

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; DNA BINDING; EMBRYO; EMBRYO DEVELOPMENT; GIANT CELL; MORPHOGENESIS; MOUSE; NIDATION; NONHUMAN; PLACENTA; PRIORITY JOURNAL; TROPHOBLAST;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GIANT CELLS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; RNA, MESSENGER; TROPHOBLASTS;

EID: 0032975032     PISSN: 0192253X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6408(1999)25:1<23::AID-DVG3>3.0.CO;2-K     Document Type: Article

References (47)

1. Alexander CM, Hansell EJ, Beherendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. 1996. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo development Development 122: 1723-1736.
2. Baeuerle P, Henkel T. 1994. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
3. h class I major histocompatibility gene. Mol Cell Biol 7:305-313.
4. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
5. Bours V, Burd PR, Brown K, Villalobos J, Park S, Rysek RP, Bravo R, Kelly K, Siebenlist U. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation throught a kB site. Mol Cell Biol 12:685-695.
6. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U. 1993. The oncoprotein Bcl-3 directly transactivates through kB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
7. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531-536.
8. Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM, Bravo R. 1998. Nuclear factor (NF)-kappa B2 (p100/ p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187:185-196.
9. Carney EW, Prideaux V, Lye SJ, Rossant J. 1993. Progressive expression of trophoblast-specific genes during formation of mouse trophoblast giant cells in vitro. Mol Reprod Dev 34:357-368.
10. Carrasco D, Ryseck R, Bravo R. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221-1231.
11. Carrasco D, Weih F, Bravo R. 1994. Developmental expression of the mouse c-rel protooncogene in hematopoietic organs. Development 120:2991-3004.
12. Colosi P, Talamantes F, Linzer DI. 1987. Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid. Mol Endocrinol 1:767-776.
13. Cross J, Werb Z, Fisher S. 1994. Implantation and the placenta: key pieces of the development puzzle. Science 266:1508-1518.
14. Ellis S, Palmer M, McMichael A. 1990. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol 144:731-735.
15. Franzoso G, Bours V, Park S, Tomita YM, Kelly K, Siebenlist U. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359:339-342.
16. Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi M, Kanno T, Brown K, Siebenlist U. 1993. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J 12:3893-3901.
17. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U. 1997. Requirement for NF-kappaB in osteoclast and B-cell development Genes Dev 11:3482-3496.
18. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U. 1998. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 187:147-159.
19. Fujita T, Nolan GP, Liou H-C, Scott ML, Baltimore D. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 1354-1363.
20. Ghosh S, Gifford A, Riviere L, Tempest P, Nolan G, Baltimore D. 1990. Cloning of the p50 DNA Binding Subunit of NF-κB: homology to re and dorsal. Cell 62:1019-1029.
21. Grilli M, Chiu J, Lenardo M. 1993. NF-κB and Rel - participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62.
22. Grumont R, Gerondakis S. 1989. Structure of mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones. Oncogene Res 4:1-8.
23. Hansen S, Nerlov C, Zabel U, Verde P, Johnsen M, Baeuerle PA, Blasi F. 1992. A novel complex between the p65 subunit of NF-κB and cRel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J 11:205-213.
24. Hoffman L, Wooding F. 1993. Giant and binucleate trophoblast cells of mammals. J Exp Zool 266:559-577.
25. Johnson MH, Rossant J. 1981. Molecular studies on cells of the trophectodermal lineage of the postimplantation mouse embryo. J Embryol Exp Morphol 61:103-116.
26. Kontgen F, Grumont R, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocytes proliferation, humoral immunity and interleukin-2 expression. Genes Dev 9:1965-1977.
27. Kovats S, Main E, Librach C, Stubbleine M, Fisher S, DeMars R. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220-223.
28. Lenardo M, Siebenlist U. 1994. Bcl-3-mediated nuclear regulation of the NF-κB trans-activating factor. Immunol Today 15:145-147.
29. Lernbecher T, Muller U, Wirth T. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770.
30. Neri A, Chang C, Lombardi L, Salina M, Corradini P, Maiolo A, Chaganti R, Della-Favera R. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
31. Nolan G, Ghosh S, Liou H, Tempst P, Baltimore D. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969.
32. Ohno H, Takimoto G, McKeithan TW. 1990. The candidate protooncogene bel-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997.
33. Parham P. 1996. Keeping mother at bay. Curr Biol 6:638-641.
34. Potter D, Larson C, Eckes P, Schmid R, Nabel G, Verdine G, Sharp P, 1993. Purification of the major histocompatibility complex class I transcription factor H2TF1. J Biol Chem 268:18882-18890.
35. Rosen B, Beddington R. 1993. Whole-mount in situ hybridization in the mouse embryo: gene expression in three dimension. TIG 9:162-167.
36. Ryseck R, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R. 1992. RelB, a new rel family transcription activator that can interact with p50-NF-κKB. Mol Cell Biol 12:674-684.
37. Sato H, Seiki M. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405.
38. Scheinman RI, Beg AA, Baldwin ASJ. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol Cell Biol 13:6089-6101.
39. Schmidt-Ullrich R, Memet S, Lilienbaum A, Feillard J, Raphael M, Israel A. 1996. NF-κB activity in transgenic mice: developmental regulation and tissue specificity. Development 122:2117-2128.
40. Sha WC, Liou HC, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
41. Talarico D, Ittmann MM, Bronson R, Basilico C. 1993. A retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas. Mol Cell Biol 13:1998-2010.
42. 2MR/LRP genes.. Mech Dev 56:103-116.
43. Thanos D, Maniatis T. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
44. Verma I, Stevenson J, Schwarz E, Van Antwerp D, Miyamoto S. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
45. Weih F, Carrasco D, Bravo R. 1994. Constitutive and inducible Rel/NFkB activities in mouse thymus and spleen.. Oncogene 9:3289-3297.
46. Weih F, Carrasco D, Durham S, Barton D, Rizzo C, Ryseck R, Lira S, Bravo R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of relB, a member of the NF-κB/Rel family. Cell 80:331-340.
47. Wilkinson DG, Bailes JA, McMahon AR.. 1987. Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 50:79-88.